Evidence map›Paper›PMID 38590672›Full record

ArticleArchives of Razi Institute2023

Apoptosis Induction by New Coumarin Derivatives in a Mice Model of Breast Cancer.

Mesgari Abbasi Mehran, Khordadmehr Monireh, Shanehbandi Dariush, Jigari Asl Farinaz, Teimuri Mofrad Reza, Tahmasebi Shabnam, Shahab Asar Mohammad, Eskandari Vaezi Fateme, Panahi Yousef

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of Razi Institute, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Mesgari Abbasi MehranDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Khordadmehr MonirehDepartment of Pathobiology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.
Shanehbandi DariushImmunology Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Jigari Asl FarinazDepartment of Pathobiology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.
Teimuri Mofrad RezaDepartment of Organic and Biochemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
Tahmasebi ShabnamDepartment of Organic and Biochemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
Shahab Asar MohammadFaculty of Veterinary Medicine, Shabestar Branch, Islamic Azad University, Shabestar, Iran.
Eskandari Vaezi FatemeDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Panahi YousefDepartment of Basic Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.
University of Tabriz · IRTabriz University of Medical Sciences · IRIslamic Azad University Shabestar · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decades, numerous studies have focused on the search for new agents to suppress the growth of cancer cells. In this study, we investigated the effect of two novel synthetic coumarin derivatives, namely

Indexed as

Antineoplastic AgentsBreast NeoplasmsAnimalsApoptosisCaspase 9Cell Line, TumorCoumarinsCyclooxygenase 2Disease Models, AnimalMiceProto-Oncogene Proteins c-bcl-2Antineoplastic AgentsCaspase 9CoumarinsCyclooxygenase 2Proto-Oncogene Proteins c-bcl-2ChemotherapyDoxorubicinNatural productsProgrammed cell death

Identifiers

PMID38590672
PMCPMC10998944
OpenAlexW4394759159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.